We are 2-methyl-2-oxazoline CAS:1120-64-5 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 2-methyl-2-oxazoline
Molecular Formula: ：C4H7NO
Physical and Chemical Properties:
Density: 1.005 g / mL at 25 ° C (lit.)
Boiling point: 109.5-110.5 ° C (lit.)
Flash point: 68 ° F
Refractive index: n20 / D 1.434 (lit.)
Appearance:Colorless to light yellow liquid
Moisture Content: 0.25%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: Mainly use in Pharmaceutical Intermediates/medical intermediate/ Research purpose.
Related News: As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory’s officials as they are struggling to contain the coronavirus outbreak.4-pentenamida, 5-cloro-N, N-dimetil-2- (1-metiletil) -, (2S, 4E) – CAS:324519-68-8 Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.indole-3-carboxylic acid CAS:771-50-6 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.5983-09-5 This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.